Literature DB >> 26935152

MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.

Xiaoying Wang1, Yanli Liu2, Xiaoli Liu3, Jingyan Yang1, Guoxin Teng1, Lulu Zhang1, Chengjun Zhou1.   

Abstract

Accumulating evidence indicates that dysregulation of microRNAs (miRNAs) may contribute to the initiation and progression of cancer. However, the role of miR-124 in lung adenocarcinoma (ADC) and the underlying mechanisms through which miR-124 exerts its functions are not completely understood. In the present study, we detected miR-124 and SOX9 expression in lung ADC tissues. The results showed that miR-124 was significantly downregulated in the lung ADC tissues compared with that noted in the corresponding non-cancerous lung tissues and the level of SOX9 protein was inversely associated with the expression of miR-124. The study in human lung ADC cell line A549 demonstrated that upregulation of miR-124 could inhibit cell proliferation, migration and invasion. The bioinformatic analysis showed that there was a putative miR-124 binding site in the 3' untranslated region (3'UTR) of SOX9. Using a luciferase reporter assay, we verified that SOX9 is a direct target of miR-124. Furthermore, overexpression of miR-124 repressed SOX9 expression, whereas inhibition of miR-124 increased expression of SOX9 in the A549 cells. Finally, we identified that SOX9 was a functional mediator of miR-124 in A549 cells. Taken together, our results suggest that miR-124 functions as a tumor suppressor in lung ADC by directly targeting SOX9 and it may be a promising candidate for miR‑based therapy against lung ADC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26935152     DOI: 10.3892/or.2016.4648

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  13 in total

1.  miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer.

Authors:  Fa-Yong Hu; Xiao-Nian Cao; Qin-Zi Xu; Yu Deng; Sen-Yan Lai; Jing Ma; Jun-Bo Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-12-07

2.  MicroRNA-30e inhibits proliferation and invasion of non-small cell lung cancer via targeting SOX9.

Authors:  Yanwei Cui; Lei Zhao; Shilei Zhao; Tao Guo; Fengzhou Li; Zhuoshi Li; Lei Fang; Taihua Wu; Chundong Gu
Journal:  Hum Cell       Date:  2019-05-11       Impact factor: 4.174

3.  Deregulation of MicroRNAs mediated control of carnitine cycle in prostate cancer: molecular basis and pathophysiological consequences.

Authors:  A Valentino; A Calarco; A Di Salle; M Finicelli; S Crispi; R A Calogero; F Riccardo; A Sciarra; A Gentilucci; U Galderisi; S Margarucci; G Peluso
Journal:  Oncogene       Date:  2017-07-03       Impact factor: 9.867

4.  Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer.

Authors:  Keli Su; Tingcui Zhang; Yongrui Wang; Guijun Hao
Journal:  World J Surg Oncol       Date:  2016-08-24       Impact factor: 2.754

5.  miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.

Authors:  Zhengwen Lei; Hongcan Shi; Wei Li; Duonan Yu; Feiyang Shen; Xi Yu; Dan Lu; Chao Sun; Kai Liao
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

6.  Genetic variants of SOX9 contribute to susceptibility of gliomas among Chinese population.

Authors:  Liang Wang; Gang Li; Nan Liu; Zhen Wang; Xiaoshan Xu; Jing Qi; Dongni Ren; Pengxing Zhang; Yongsheng Zhang; Yanyang Tu
Journal:  Oncotarget       Date:  2016-10-04

7.  High-intensity focused ultrasound inhibits invasion and metastasis of colon cancer cells by enhancing microRNA-124-mediated suppression of STAT3.

Authors:  Meiying Li; Guangsheng Wan; Hongjie Yu; Wei Xiong
Journal:  FEBS Open Bio       Date:  2019-05-04       Impact factor: 2.693

8.  Decreased expression of microRNA-145 promotes the biological functions of fibroblasts in hypertrophic scar tissues by upregulating the expression of transcription factor SOX-9.

Authors:  Shoujie Wang; Caiyun Li; Yijia Yu; Jianjun Qiao
Journal:  Exp Ther Med       Date:  2019-09-05       Impact factor: 2.447

9.  Decoding the Emerging Patterns Exhibited in Non-coding RNAs Characteristic of Lung Cancer with Regard to their Clinical Significance.

Authors:  Laura Sonea; Mihail Buse; Diana Gulei; Anca Onaciu; Ioan Simon; Cornelia Braicu; Ioana Berindan-Neagoe
Journal:  Curr Genomics       Date:  2018-05       Impact factor: 2.236

10.  LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.

Authors:  Bin Yang; Lin Jia; Hui Ren; Caibao Jin; Qingrong Ren; Haiyuan Zhang; Desheng Hu; Hao Zhang; Liu Hu; Tao Xie
Journal:  Mol Genet Genomic Med       Date:  2019-11-29       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.